IBRUTINIB 140MG Y VENETOCLAX 100 MG
Instituto Nacional del Cancer | Bienestar tender for Professional Services & Consulting, worth CLP$127M, published in February 2026.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
IBRUTINIB 140MG Y VENETOCLAX 100 MG
Other tenders · Instituto Nacional del Cancer | Bienestar
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-70d2nz-359-162-LP25CLP$72.5M31 Dec 2025 Healthcare
- ocds-70d2nz-359-157-LE25CLP$42.3M23 Dec 2025 Professional Services
- ocds-70d2nz-359-129-LR25CLP$370M04 Nov 2025 Professional Services
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime